New Jersey Statutes Title 24. Food and Drugs 24 § 6I-17

a. (1) Each batch of medical cannabis cultivated by a medical cannabis cultivator or a clinical registrant and each batch of a medical cannabis product manufactured by a medical cannabis manufacturer or a clinical registrant shall be tested in accordance with the requirements of section 26 of P.L.2019, c. 153 (C.24:6I-19) by a laboratory licensed pursuant to section 25 of P.L.2019, c. 153 (C.24:6I-18) or cannabis testing facility licensed pursuant to section 18 of P.L.2021, c. 16 (C.24:6I-35). The laboratory or facility performing the testing shall produce a written report detailing the results of the testing, a summary of which shall be included in any packaging materials for medical cannabis and medical cannabis products dispensed to qualifying patients and their designated and institutional caregivers. The laboratory or facility may charge a reasonable fee for any test performed pursuant to this section.

(2) Each sample of usable cannabis, cannabis products, cannabis extracts, or other cannabis resins from a cannabis cultivator or cannabis manufacturer may be tested in accordance with the provisions of section 18 of P.L.2021, c. 16 (C.24:6I-35) by a laboratory licensed pursuant to section 25 of P.L.2019, c. 153 (C.24:6I-18).